Dr Dipty Jain

Dipty Jain

Dr Dipty Jain

MBBS MD Pediatrics, MSc (Med) Canada.

Dr. Dipty Jain is a distinguished pediatrician and hematology expert dedicated to advancing care for sickle cell disease (SCD) in India and globally. She completed her MBBS and MD at Nagpur University and earned a Master’s in Medicine at McMaster University, Canada, as a Rockefeller Fellow. She began her academic career at Government Medical College, Nagpur, in 1984 and served as Professor and Head of Pediatrics from 2006 to 2022.

A pioneer in SCD care, Dr. Jain established India’s first Center of Excellence for SCD at Government Medical College, Nagpur. Her work has shaped context-specific treatment approaches, including low-dose hydroxyurea, newborn screening, and transcranial Doppler implementation. She has also contributed to research on the Arab-Indian haplotype and the development of national care models and policies.

In 2023, she was appointed Chairperson of India’s National Sickle Cell Anaemia Elimination Mission Task Force. She is actively involved in global collaborations and has authored over 100 publications. Dr. Jain is a recipient of the 2024 Ham Wasserman Lecture Award from the American Society of Hematology.

Read more +

Dr. Biree Andemariam

Dr. Biree Andemariam

Dr. Biree Andemariam

Professor of Medicine & Director, New England Sickle Cell Institute

Dr. Biree Andemariam is a Professor of Medicine and the American Red Cross Endowed Chair in Transfusion Medicine at the University of Connecticut School of Medicine. She is an internationally recognized clinician, educator, and advocate, and serves as Founding Director of the New England Sickle Cell Institute (NESCI) and Director of the Connecticut Bleeding Disorders Center.

Through NESCI, she provides comprehensive care for over 350 adults with sickle cell disease (SCD), while advancing clinical and translational research. Dr. Andemariam has led multiple global SCD clinical trials and has extensive expertise in trial design, implementation, and patient-centered outcomes.

During the COVID-19 pandemic, she chaired an international committee that developed widely adopted guidelines for managing SCD patients. She is a former Chief Medical Officer of the Sickle Cell Disease Association of America, where she received the Chairman’s Award three times for her leadership in advocacy, education, and national program development.

Dr. Andemariam is also a member of the 2023 Lancet Commission, contributing to global strategies to improve outcomes for individuals living with SCD by 2040.

Read more +

Dr K.Saroja

Saroja Kondaveeti

Dr K.Saroja

Medical Officer

Dr. K. Saroja is a dedicated Medical Officer associated with the Thalassemia and Sickle Cell Society, Hyderabad,India with over 14 years of experience in managing thalassemia and sickle cell anemia. Her journey began with a strong commitment to improving the quality of care for patients with thalassemia and sickle cell anemia, and over time she has developed significant expertise in their comprehensive management.

She played a key role in streamlining patient care services by establishing structured systems for blood transfusion scheduling, consultations, and counseling. Dr. Saroja has been instrumental in designing and implementing prevention programs, particularly through antenatal counseling for carrier couples, enabling them to make informed decisions. She has also contributed to capacity building by training paramedical staff at the grassroots level.

An active contributor to academic and professional forums, she has been part of the organizing committee for three national conferences and two CME programs for gynecologists and obstetricians. Under her guidance, more than 150 thalassemia patients were successfully prepared for bone marrow transplants.
In addition, she actively conducts monthly awareness and counseling programs for sickle cell patients and parents and has organized cultural initiatives. She is also a qualified child nutritionist and holds expertise in hospital management.

Read more +

Dr. Suman Jain

Dr Suman Jain

Dr. Suman Jain

Chief Medical Research Officer and Secretary

Dr. Suman Jain is a pediatrician and public health researcher with over two decades of experience in the diagnosis, treatment, and prevention of hemoglobinopathies, particularly thalassemia and sickle cell disease. She currently serves as the Chief Medical Research Officer and Secretary at the Thalassemia & Sickle Cell Society (TSCS), Hyderabad. In this role, she leads clinical research, patient care programs, and large-scale screening initiatives aimed at improving the quality of life for affected patients and preventing the birth of children with severe genetic blood disorders.

Dr. Jain completed her MBBS from Calcutta University in 1985 and obtained a Diploma in Child Health (DCH) from the College of Physicians & Surgeons, Mumbai, in 1991. Over the course of her career, she has worked with several prominent institutions including the LEPRA Society Blue Peter Research Centre, the Institute of Genetics at Osmania University, and the National Institute for Mentally Handicapped.

Her research focuses on genetic screening, prenatal diagnosis, molecular diagnostics, and innovative therapeutic strategies for hemoglobin disorders. She has been actively involved in multiple collaborative projects related to gene editing, genomic diagnostics, and disease burden studies in thalassemia and sickle cell disease. Dr. Jain has authored numerous scientific publications in reputed national and international journals and has contributed to global studies on hemoglobinopathies.

She has received several recognitions, including international travel support from the Indian Council of Medical Research and the prestigious Renzo Galanello Fellowship from the Thalassaemia International Federation, where she underwent advanced training at University College London Hospitals, UK.

Read more +

Dr G Padma

Dr Padma G

Dr G Padma

Research Scientist

Dr. Padma G is a molecular geneticist with over 18 years of experience in the diagnosis, research, and prevention of inherited blood disorders, particularly thalassemia and sickle cell anemia. She serves as Head of the Molecular Genetics Laboratory at the Thalassemia and Sickle Cell Society, where she leads diagnostic services, research initiatives, and oversees genetic reporting.

Her expertise spans molecular genetics, bioinformatics, and clinical research. Her early work at Osmania University focused on genetic factors in hypertension, DNA repair in cataracts, and congenital hearing impairment. Since 2018, she has specialized in hemoglobinopathies, contributing to antenatal and cascade screening programs, diagnostic validation, and studies on iron overload in thalassemia.

Dr. Padma has been involved in multi-centre clinical trials, including studies on nutraceuticals for sickle cell disease and emerging therapies such as Luspatercept. She has published extensively in peer-reviewed journals and contributed to research on β-thalassemia, sequencing-based screening, and novel genetic variants.

An active member of ethics committees and organizer of national conferences and CMEs, she is committed to advancing early detection, improved care, and prevention of inherited blood disorders in India.

Read more +

Scientific Program Committee 2026